EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSDLAG00005016721
Gene Symbol: KIF5B
1 Cross references
243 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSDLAG00005025380
Gene Symbol: LGALS3A
1 Cross references
219 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSDLAG00005005516
Gene Symbol: LTB4R
1 Cross references
143 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSDLAG00005003304
Gene Symbol: LTB4R2B
1 Cross references
167 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSDLAG00005001834
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSDLAG00005023456
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Matrix Metallopeptidase 13a

Ensembl ID : ENSDLAG00005008130
Gene Symbol: MMP13A
1 Cross references
310 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSDLAG00005006759
Gene Symbol: MMP14A
1 Cross references
199 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSDLAG00005019935
Gene Symbol: MMP14B
1 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSDLAG00005001814
Gene Symbol: MMP2
1 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSDLAG00005018682
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSDLAG00005017519
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).